KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 82 filers reported holding KRONOS BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365,228 | -24.7% | 292,182 | 0.0% | 0.29% | -25.1% |
| Q2 2023 | $485,022 | +6.4% | 292,182 | 0.0% | 0.38% | +6.4% |
| Q1 2023 | $455,804 | -23.8% | 292,182 | -20.9% | 0.36% | -20.9% |
| Q4 2022 | $598,431 | -72.3% | 369,402 | -42.8% | 0.45% | -83.5% |
| Q3 2022 | $2,162,000 | +38.1% | 645,331 | +50.0% | 2.76% | +55.5% |
| Q2 2022 | $1,566,000 | – | 430,349 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $4,037,358 | 5.52% |
| Omega Fund Management, LLC | 3,818,283 | $5,574,693 | 3.64% |
| Nextech Invest Ltd. | 1,451,537 | $2,119,244 | 0.88% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,895,020 | 0.70% |
| Privium Fund Management (UK) Ltd | 292,182 | $455,804 | 0.36% |
| CM Management, LLC | 180,000 | $263 | 0.31% |
| Artal Group S.A. | 1,542,954 | $2,253 | 0.13% |
| Alphabet Inc. | 1,438,232 | $2,099,819 | 0.12% |
| Perceptive Advisors | 1,752,745 | $2,558,131 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 406,362 | $593 | 0.06% |